rabies vaccine

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Rabies Post-exposure Prophylaxis

Conditions

Rabies Post-exposure Prophylaxis

Trial Timeline

Mar 1, 2006 → May 1, 2006

NCT ID

NCT00345319

About rabies vaccine

rabies vaccine is a phase 3 stage product being developed by Novartis for Rabies Post-exposure Prophylaxis. The current trial status is completed. This product is registered under clinical trial identifier NCT00345319. Target conditions include Rabies Post-exposure Prophylaxis.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00345319	Phase 3	Completed	Mar 1, 2006	May 1, 2006	Rabies Post-exposure Prophylaxis

Competing Products

20 competing products in Rabies Post-exposure Prophylaxis

See all competitors

Product	Company	Stage	Hype Score
Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 schedule	Novartis	Phase 3	77
Three 1 mL doses of Rabies vaccine and two JE vaccine + Three 0.5 mL doses of Rabies vaccine and two JE vaccine + Three 0.1mL doses of Rabies Vaccine and two JE vaccine + Two 0.1mL doses of Rabies vaccine and two JE vaccine + Two doses of JE vaccine	Novartis	Phase 2	52
Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulins	Novartis	Phase 3	77
Zagreb + Essen	Novartis	Phase 3	77
Rabies + Japanese Encephalitis	Novartis	Phase 3	77
Purified Chick Embryo Cell Inactivated Rabies Vaccine	Novartis	Approved	85
Intramuscular (IM) rabies post-exposure prophylaxis + Intradermal (ID) rabies post-exposure prophylaxis	Sanofi	Pre-clinical	22
Purified vero rabies vaccine - serum free + Purified inactivated rabies vaccine + Human rabies immunoglobulins	Sanofi	Phase 3	76
VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)	Sanofi	Phase 3	76
Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® Rabies	Sanofi	Phase 3	76
HDCV + HDCV + PVRV + PVRV	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine (VRVg) - Serum Free + Imovax® Rabies: inactivated rabies vaccine	Sanofi	Phase 2	51
Purified inactivated rabies vaccine, serum free + Purified inactivated rabies vaccine, serum free + Purified Vero Rabies Vaccine + Purified Vero Rabies Vaccine	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),	Sanofi	Phase 2	51
Purified vero rabies vaccine - serum free VRVg-2 + Purified inactivated rabies vaccine + Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4) + Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)	Sanofi	Phase 3	76
Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccine	Sanofi	Phase 2	51
Purified Verocell Rabies Vaccine + Purified Verocell Rabies Vaccine + Purified Verocell Rabies Vaccine	Sanofi	Approved	84
VRVg 2 + VRVg 1 + Imovax Rabies + VRVg 2 + VRVg 2 + Human Rabies Immunoglobulins (HRIG)	Sanofi	Phase 2	51
Purified Vero Rabies Vaccine - Serum Free + Purified inactivated rabies vaccine	Sanofi	Phase 2	51
PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab®	Sanofi	Phase 3	76

Other Products from Novartis

LCZ696Approved

zoledronic acidApproved

NateglinideApproved

TenofovirApproved

FTY720Approved